Dominique ROULOT
Hospital Avicenne · Hopital Avicenne, APHP · Bobigny University Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Dominique ROULOT as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 00:24 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT02319200 · Primary Prevention Hepatocellular Carcinoma by MetforminAssistance Publique - Hôpitaux de Paris · terminated · Hepatocellular Carcinoma, Hepatitis C, Chronic, Cirrhosis · principal investigator
- Ph2NCT02309450 · Pilot Study to Assess Efficacy and Safety of a Triple Therapy With Asunaprevir, Daclatasvir, and BMS-791325 in HCV Genotype 4-infected Patients After Failure of Pegylated Interferon-Ribavirin RegimenANRS, Emerging Infectious Diseases · withdrawn · Hepatitis C Virus Genotype 4 Infection · principal investigator
- Ph2NCT02107365 · Therapy With Asunaprevir, Daclatasvir, Ribavirin and Pegylated Interferon Alpha-2a in HCV Genotype 4-infected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin (ANRS HC32 QUATTRO)ANRS, Emerging Infectious Diseases · completed · Hepatitis C Virus Genotype 4 Infection · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 00:24 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 00:24 UTC. The ranking covers the 200 most relevant of 12 PubMed records, and a shared surname and initials can bring in a namesake. All 12 on PubMed
- Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study.Hepatology · 2015364 citationsRCR 15.5
- Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: a randomized trial comparing 3- and 6-month periodicities.Hepatology · 2011304 citationsRCR 8.4
- Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trial.J Hepatol · 1998135 citationsRCR 3.7
- Nadolol for prophylaxis of gastrointestinal bleeding in patients with cirrhosis. A randomized trial.J Hepatol · 1988133 citationsRCR 5.3
- Nomogram for individualized prediction of hepatocellular carcinoma occurrence in hepatitis C virus cirrhosis (ANRS CO12 CirVir).Hepatology · 201672 citationsRCR 2.3
- Concomitant screening for liver fibrosis and steatosis in French type 2 diabetic patients using Fibroscan.Liver Int · 201770 citationsRCR 2.7
- Randomized comparative multicenter study of hydroxyethyl starch versus albumin as a plasma expander in cirrhotic patients with tense ascites treated with paracentesis.Eur J Gastroenterol Hepatol · 199850 citationsRCR 1.6
- Treatment of mixed cryoglobulinemia with recombinant interferon alpha and adjuvant therapies. A prospective study on 20 patients.Ann Med Interne (Paris) · 199639 citationsRCR 1.5
- Long-term sympathetic and hemodynamic responses to clonidine in patients with cirrhosis and ascites.Gastroenterology · 199236 citationsRCR 1.6
- Effect of prolonged interferon therapy on the outcome of hepatitis C virus-related cirrhosis: a randomized trial.Clin Gastroenterol Hepatol · 200735 citationsRCR 0.8